肝癌合并食管静脉曲张出血的治疗现状

彭忠; 祁兴顺; 郭晓钟

doi:10.3969/j.issn.1001-5256.2017.07.035

肝癌合并食管静脉曲张出血的治疗现状

DOI: 10.3969/j.issn.1001-5256.2017.07.035

1. 大连医科大学研究生院
2. 沈阳军区总医院消化内科

详细信息

中图分类号: R735.7
计量
- 文章访问数: 1534
- HTML全文浏览量: 29
- PDF下载量: 394
- 被引次数: 0
出版历程
- 收稿日期: 2016-12-26
- 出版日期: 2017-07-20

Current status of treatment of liver cancer complicated by esophageal variceal bleeding

Graduate School, Dalian Medical University

摘要

摘要: 食管静脉曲张出血是肝癌的主要并发症及死亡原因。综述了肝癌合并食管静脉曲张出血的治疗方法,主要包括药物(血管加压素及其类似物、生长抑素及其类似物及抗生素),内镜(静脉曲张套扎及硬化治疗)和介入(经皮静脉支架置入及经颈静脉肝内门体分流术)治疗,重点讨论了肝癌合并食管静脉曲张出血的治疗选择。
- 肝肿瘤 /
- 食管和胃静脉曲张 /
- 出血 /
- 治疗 /
- 综述
Abstract: Esophageal variceal bleeding is a major complication of liver cancer and a major cause of death in patients with liver cancer.This article summarizes the current status of the treatment of liver cancer complicated by esophageal variceal bleeding, including drugs and endoscopic and interventional treatment, with an emphasis on treatment options for liver cancer complicated by esophageal variceal bleeding.
- liver neoplasms /
- esophageal and gastric varices /
- hemorrhage /
- therapy /
- review

HTML全文

参考文献(28)

[1]ZHU PL, YIN C, FENG JL.Progress in comprehensive treatment of primary liver cancer[J].J Clin Hepatol, 2015, 31 (6) :965-968. (in Chinese) 祝普利, 尹超, 冯建龙.原发性肝癌综合治疗进展[J].临床肝胆病杂志, 2015, 31 (6) :965-968.

[2]HAN ML, CHEN CC, KUO SH, et al.Predictors of in-hospital mortality after acute variceal bleeding in patients with hepatocellular carcinoma and concurrent main portal vein thrombosis[J].Gastroenterol Hepatol, 2014, 29 (2) :344-351.

[3]KIM JH, SINN DH, KIM K, et al.Primary prophylaxis for variceal bleeding and the improved survival of patients with newly diagnosed hepatocellular carcinoma[J].Dig Dis Sci, 2016, 61 (11) :3354-3362.

[4]RIPOLL C, GENESCA J, ARAUJO IK, et al.Rebleeding prophylaxis improves outcomes in patients with hepatocellular carcinoma.A multicenter case-control study[J].Hepatology, 2013, 58 (6) :2079-2088.

[5]STTREBA LA, VERE CC, ROGOVEANU I, et al.Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma:an open question[J].World J Gastroenterol, 2015, 21 (14) :4103-4110.

[6]CHENG HY.Intercentional treatment for hepatocellular carcinoma:a review current perscives[J].J Clin Hepatol, 2016, 32 (1) :3-8. (in Chinese) 程红岩.肝癌介入治疗的现状与展望[J].临床肝胆病杂志, 2016, 32 (1) :3-8.

[7]CHEN LJ, YANG RJ, ZHU LZ, et al.Imaging characteristics and intervention therapy for hepatic artery-portal vein shunts in patients with primary liver carcinoma[J].Chin J Clin Oncol, 2015, 42 (11) :570-575. (in Chinese) 陈立军, 杨仁杰, 朱林忠, 等.原发性肝癌介入术中肝动脉-门静脉瘘的影像学特点及治疗[J].中国肿瘤临床, 2015, 42 (11) :570-575.

[8]SERENII CP, RODGERS SK, KIRBY CL, et al.Portal vein thrombus and infiltrative HCC:a pictoral review[J].Abdom Radiol (NY) , 2017, 42 (1) :159-170.

[9]IOANNOU GN, DOUST J, ROCKEY DC, et al.Systematic review:terlipressin in acute oesophageal variceal haemorrhage[J].Aliment Pharmacol Ther, 2003, 17 (1) :53-64.

[10]WELLS M, CHANDE N, ADAMS P, et al.Meta-analysis:vasoactive medications for the management of acute variceal bleeds[J].Aliment Pharmacol Ther, 2012, 35 (11) :1267-1278.

[11]AUGUSTIN S, ALTAMIRANO J, GONZALEZ A, et al.Effectiveness of combined pharmacologic and ligation therapy in high-risk patients with acute esophageal variceal bleeding[J].Am J Gastroenterol, 2011, 106 (10) :1787-1795.

[12]AGARWAL A, KUMAR SS, SADASIVAN J, et al.Antibiotic prophylaxis in the prevention of rebleeding in acute variceal hemorrhage:a randomized trial[J].J Pharmacol Pharmacother, 2015, 6 (1) :24-29.

[13]FERNNDEZ J, RUIZ DEL ARBOL L, GMEZ C, et al.Norfloxacin vs ceftriaxone in the prophylaxis of infections in patients with advanced cirrhosis and hemorrhage[J].Gastroenterology, 2006, 131 (4) :1049-1056.

[14]LEE YY, TEE HP, MAHADEVA S.Role of prophylactic antibiotics in cirrhotic patients with variceal bleeding[J].World J Gastroenterol, 2014, 20 (7) :1790-1796.

[15]PAQUET KJ, FEUSSNER H.Endoscopic sclerosis and esophageal balloon tamponade in acute hemorrhage from esophagogastric varices:a prospective controlled randomized trial[J].Hepatology, 1985, 5 (4) :580-583.

[16]LAINE L, EL-NEWIHI HM, MIGIKOVSKY B, et al.Endoscopic ligation compared with sclerotherapy for the treatment of bleeding esophageal varices[J].Ann Intern Med, 1993, 119 (1) :1-7.

[17]LO GH, LAI KH, CHANG CF, et al.Endoscopic injection sclerotherapy vs.endoscopic variceal ligation in arresting acute variceal bleeding for patients with advanced hepatocellular carcinoma[J].J Hepatol, 1994, 21 (6) :1048-1052.

[18]CHEN CY, CHANG TT, LIN CY, et al.Endoscopic variceal ligation versus conservative treatment for patients with hepatocellular carcinoma and bleeding esophageal varices[J].Gastrointest Endosc, 1995, 42 (6) :535-539.

[19]KAWAI T, YASHIMA Y, SUGIMOTO T, et al.Emergency endoscopic variceal ligation following variceal rupture in patients with advanced hepatocellular carcinoma and portal vein tumor thrombosis:a retrospective study[J].World J Surg Oncol, 2016, 14 (1) :52.

[20]CHEN WC, HOU MC, LIN HC, et al.Feasibility and potential benefit of maintenance endoscopic variceal ligation in patients with unresectable hepatocellular carcinoma and acute esophageal variceal hemorrhage:a controlled trial[J].Gastrointest Endosc, 2001, 54 (1) :18-23.

[21]ZHANG XB, WANG JH, YAN ZP, et al.Hepatocellular carcinoma invading the main portal vein:treatment with transcatheter arterial chemoembolization and portal vein stenting[J].Cardiovasc Intervent Radiol, 2009, 32 (1) :52-61.

[22]ISHIKAWA T, KUBOTA T, ABE H, et al.Percutaneous transhepatic portal vein stent placement can improve prognosis for hepatocellular carcinoma patients with portal vein tumor thrombosis[J].Hepatogastroenterology, 2014, 61 (130) :413-416.

[23]GONG GQ, WANG XL, ZHOU KR, et al.Metallic stent treatment of portal cancerous thrombus in primary hepatic carcinoma:a report of 19 cases[J].J Clin Radiol, 2003, 22 (6) :498-500. (in Chinese) 龚高全, 王小林, 周康荣, 等.肝癌伴门静脉癌栓的金属内支架治疗的初步研究[J].临床放射学杂志, 2003, 22 (6) :498-500.

[24]ANGERMAYR B.Transjugular intrahepatic portosystemic shunt-current status in 2011[J].Acta Gastroenterol Belg, 2011, 74 (4) :553-559.

[25]QIU B, ZHAO MF, YUE ZD, et al.Combined transjugular intrahepatic portosystemic shunt and other interventions for hepatocellular carcinoma with portal hypertension[J].World J Gastroenterol, 2015, 21 (43) :12439-12447.

[26]CHEN DX, PANG HJ, LI C.Interventional treatment in primary hepatocellular carcinoma patients with portal hypertension[J].China Modern Med, 2013, 20 (17) :117-118, 121. (in Chinese) 陈德雄, 庞桦进, 李冲.经颈静脉肝内门静脉分流术介入治疗原发性肝癌合并门静脉高压症的临床研究[J].中国当代医药, 2013, 20 (17) :117-118, 121.

[27]ZHAO JB, FENG C, ZHU QH, et al.Transjugular intrahepatic portosystemic shunt with covered stents for hepatocellular carcinoma with portal vein tumor thrombosis[J].World J Gastroenterol, 2014, 20 (6) :1602-1607.

[28]LIU L, ZHAO Y, QI X, et al.Transjugular intrahepatic portosystemic shunt for symptomatic portal hypertension in hepatocellular carcinoma with portal vein tumor thrombosis[J].Hepatol Res, 2014, 44 (6) :621-630.

施引文献

资源附件(0)

访问统计